CryoPort, Inc. $CYRX Shares Sold by New York State Common Retirement Fund

New York State Common Retirement Fund trimmed its holdings in CryoPort, Inc. (NASDAQ:CYRX) by 98.6% during the third quarter, Holdings Channel.com reports. The fund owned 15,765 shares of the company’s stock after selling 1,129,781 shares during the period. New York State Common Retirement Fund’s holdings in CryoPort were worth $149,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Assenagon Asset Management S.A. grew its holdings in CryoPort by 37.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,498,774 shares of the company’s stock valued at $14,208,000 after buying an additional 408,263 shares during the last quarter. Y Intercept Hong Kong Ltd purchased a new position in CryoPort in the 2nd quarter valued at about $292,000. SG Americas Securities LLC lifted its holdings in CryoPort by 663.2% in the 3rd quarter. SG Americas Securities LLC now owns 127,280 shares of the company’s stock valued at $1,207,000 after purchasing an additional 110,602 shares in the last quarter. Conestoga Capital Advisors LLC boosted its stake in shares of CryoPort by 55.9% during the 2nd quarter. Conestoga Capital Advisors LLC now owns 110,557 shares of the company’s stock worth $825,000 after purchasing an additional 39,640 shares during the last quarter. Finally, Thematics Asset Management grew its holdings in shares of CryoPort by 12.8% during the second quarter. Thematics Asset Management now owns 1,914,885 shares of the company’s stock worth $14,285,000 after buying an additional 216,937 shares in the last quarter. Institutional investors and hedge funds own 92.90% of the company’s stock.

CryoPort Stock Performance

Shares of NASDAQ:CYRX opened at $8.50 on Thursday. The business has a fifty day moving average of $9.84 and a 200-day moving average of $9.35. The company has a debt-to-equity ratio of 0.40, a quick ratio of 15.01 and a current ratio of 15.77. CryoPort, Inc. has a twelve month low of $4.58 and a twelve month high of $11.45. The firm has a market cap of $425.60 million, a PE ratio of 7.27 and a beta of 1.66.

Analysts Set New Price Targets

CYRX has been the topic of a number of analyst reports. Weiss Ratings restated a “sell (d+)” rating on shares of CryoPort in a research report on Monday, December 29th. Needham & Company LLC raised their price objective on CryoPort from $11.00 to $12.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Finally, UBS Group upped their target price on CryoPort from $11.00 to $12.50 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Eight investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, CryoPort presently has a consensus rating of “Moderate Buy” and an average target price of $12.83.

Insiders Place Their Bets

In other CryoPort news, Director Ramkumar Mandalam sold 11,570 shares of the business’s stock in a transaction dated Wednesday, December 10th. The shares were sold at an average price of $9.99, for a total value of $115,584.30. Following the completion of the transaction, the director directly owned 80,758 shares of the company’s stock, valued at approximately $806,772.42. The trade was a 12.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 10.00% of the company’s stock.

CryoPort Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.